MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock upon...
$4,597K
(63.77%↑ Y/Y)
Proceeds from issuance of
common stock for espp
$2,376K
(38.70%↑ Y/Y)
Net cash provided by
financing activities
$6,973K
(-89.47%↓ Y/Y)
Effect of exchange rate
changes on cash
$168K
(171.49%↑ Y/Y)
Net increase
(decrease) in cash, cash...
-$28,737K
(-65.43%↓ Y/Y)
Canceled cashflow
$7,141K
Proceeds from maturities
and sales of...
$227,419K
Accrued liabilities
$50,044K
(56.23%↑ Y/Y)
Stock-based compensation
expense
$40,364K
(-3.27%↓ Y/Y)
Amortization of intangible
assets
$4,667K
(138.23%↑ Y/Y)
Non-cash interest
expense
$1,756K
(-67.51%↓ Y/Y)
Other non-cash items,
net
-$652K
Net cash provided by
(used in) investing...
-$30,253K
(-204.97%↓ Y/Y)
Canceled cashflow
$227,419K
Net cash used in
operating activities
-$5,625K
(94.98%↑ Y/Y)
Canceled cashflow
$97,483K
Interest income
$8,897K
Other income
(expense), net
$443K
(-97.26%↓ Y/Y)
Purchases of marketable
securities
$246,986K
(-3.07%↓ Y/Y)
Milestone payment for
intangible asset
$10,000K
(100.00%↑ Y/Y)
Purchases of property and
equipment
$686K
(379.72%↑ Y/Y)
Accounts receivable, net
$73,163K
(54.81%↑ Y/Y)
Net loss
-$16,141K
(88.47%↑ Y/Y)
Inventories
$7,329K
(1732.25%↑ Y/Y)
Net accretion on
marketable securities
$2,094K
(-69.66%↓ Y/Y)
Prepaid expenses and
other current assets
$2,007K
(111.71%↑ Y/Y)
Accounts payable
-$1,694K
(-176.00%↓ Y/Y)
Operating lease
liabilities
-$680K
(7.48%↑ Y/Y)
Canceled cashflow
$9,340K
Loss from operations
-$12,227K
(90.48%↑ Y/Y)
Interest expense
$12,083K
(-55.52%↓ Y/Y)
Provision for income taxes
$1,171K
(80.99%↑ Y/Y)
Back
Back
Cash Flow
source: myfinsight.com
logo-arcutis (1)-svg
Arcutis Biotherapeutics, Inc. (ARQT)
logo-arcutis (1)-svg
Arcutis Biotherapeutics, Inc. (ARQT)